Zimmer Biomet Holdings (XSWX:ZBH) Cash per Share: CHF1.73 (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Zimmer Biomet Holdings Inc XSWX:ZBH

What is Zimmer Biomet Holdings Cash per Share?

Zimmer Biomet Holdings XSWX:ZBH 76 Cash per Share is CHF1.73 as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 76/100 and a GF Value™ of CHF103.81. The stock has 3 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Zimmer Biomet Holdings's Cash per Share for the quarter that ended in Mar. 2026 was CHF1.73.

Zimmer Biomet Holdings (XSWX:ZBH) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Zimmer Biomet Holdings Cash per Share Related Terms

Zimmer Biomet Holdings Cash per Share Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Cash per Share Chart

Zimmer Biomet Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

1.67

1.68

1.75

2.35

2.41

Zimmer Biomet Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Cash per Share	Get a 7-Day Free Trial															6.18	2.29	5.19	2.41	1.73

76GF Score

Zimmer Biomet Holdings Inc XSWX:ZBH

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Zimmer Biomet Holdings Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Zimmer Biomet Holdings's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	471.685	/	195
	=	2.41

Zimmer Biomet Holdings's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	333.973	/	193
	=	1.73

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of CHF1.73 mean?

Zimmer Biomet Holdings (XSWX:ZBH) has a Cash per Share of CHF1.73 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Zimmer Biomet Holdings and its competitors.

Is Zimmer Biomet Holdings' Cash per Share too high?

Zimmer Biomet Holdings' current Cash per Share is CHF1.73. Overall, Zimmer Biomet Holdings has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.

How does Zimmer Biomet Holdings' Cash per Share compare to STE and PEN?

Zimmer Biomet Holdings' Cash per Share of CHF1.73 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Medical Devices & Instruments company?

A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Cash per Share is CHF1.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Zimmer Biomet Holdings stock overvalued right now?

Zimmer Biomet Holdings (XSWX:ZBH) has a current Cash per Share of CHF1.73. The stock's GF Value™ is CHF103.81, compared to a current price of CHF75.00 — trading 27.8% below its estimated fair value. The current Cash per Share is CHF1.73. Zimmer Biomet Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Cash per Share is CHF1.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF75.00 is trading 27.8% below its estimated GF Value™ of CHF103.81.

Key valuation signals for XSWX:ZBH:

Cash per Share: CHF1.73
GF Value™: CHF103.81 vs. price of CHF75.00 (27.8% below fair value)
GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies STE PEN PODD GMED BRKR GKOS BIO GEHC DXCM LIVN ABT SYK MDT BSX EW XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271

Other Exchanges ZBH:USA ZBH:Mexico 1ZBH:Italy ZIM:Germany Z1BH34:Brazil ZBH:Austria

Address 345 East Main Street, Warsaw, IN, USA, 46580

Website https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

76GF Score

Get the complete analysis for XSWX:ZBH

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF75.00

Price

CHF103.81

GF Value

View XSWX:ZBH Analysis

See Cash per Share data for all stocks →